Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study

Erica L. Mayer, Michael Gnant, Arlene Chan et al.|The Lancet Oncology|2021

Cited by 255